ANA L MORALES-AMAYA

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology FRIENDSWOOD, TX NPI 1619979903

General Payments — all program years on this page

$3,517.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 121
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $521.85 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $521.8517

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $459.5414
Lilly USA, LLC $62.313

By program year

Program yearAmountRecords
2018 $380.5915
2019 $857.1424
2020 $320.7116
2021 $400.8215
2022 $504.3817
2023 $532.2617
2024 $521.8517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096571974 Novo Nordisk Inc $26.72 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096589518 Novo Nordisk Inc $13.26 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096888896 Novo Nordisk Inc $2.94 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097039870 Novo Nordisk Inc $24.55 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097115812 Novo Nordisk Inc $121.86 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097200846 Novo Nordisk Inc $16.02 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097211911 Novo Nordisk Inc $23.50 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097234479 Novo Nordisk Inc $122.12 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097252390 Novo Nordisk Inc $24.49 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097279745 Novo Nordisk Inc $28.63 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097370208 Novo Nordisk Inc $22.42 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097503963 Novo Nordisk Inc $6.65 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097645937 Novo Nordisk Inc $14.59 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097682694 Novo Nordisk Inc $11.79 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136029637 Lilly USA, LLC $21.24 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136038519 Lilly USA, LLC $19.54 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136046829 Lilly USA, LLC $21.53 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.